Two types of host defense systems |
|
innate and adaptive immunity |
| |
first line of defense; nonspecific; always present |
|
innate immunity |
| |
specific or acquired defense |
|
adaptive immunity |
| |
two major classes of lymphocytes in adaptive immunity |
|
B and T cells |
| |
lymphocyte most responsible for the clearance of extracellular microbes |
|
B cells |
| |
lymphocyte population most responsible for the clearance of intracellular microbes |
|
T cells |
| |
classes of T cells |
|
helper, cytolytic, regulatory |
| |
substance, usually foreign, that reacts with an antibody |
|
antigen |
| |
substance, usually foreign that elicits an immune response |
|
immunogen |
| |
lymphocyte population that secretes antibodies |
|
B cells (plasma cells) |
| |
lymphocyte population that directly kills infected cells |
|
cytotoxic T cells |
| |
lymphocyte population that helps B cells make antibodies |
|
T helper cells |
| |
lymphocyte population that helps activate macrophages |
|
T helper cells |
| |
active immunity that is naturally acquired |
|
recovery from infection |
| |
active immunity that is artificially acquired |
|
vaccination |
| |
passive immmunity that is artificially acquired |
|
injection of immune globulin |
| |
passive immunity that is naturally acquired |
|
placental transfer of IgG |
| |
passive immunity that is naturally acquired |
|
breast feeding of IgA |
| |
Maturation stage of a mature lymphocyte that has not yet engaged antigen |
|
naive lymphocyte |
| |
maturation stage of a mature lymphocyte that has been activated by antigen |
|
effector lymphocyte |
| |
maturation stage of mature lymphocyte that is long lived and ready to rapidly respond to antigen on the second/subsequent exposures |
|
memory lypmphocyte |
| |
secondary lymphoid tissue where the response occurs to blood-borne antigens |
|
spleen |
| |
secondary lymphoid tissue where the response occurs to tissue-borne antigens |
|
lymph nodes, MALT, GALT, BALT |
| |
major cell types involved in innate immunity |
|
granulocytes, macrophages, dendritic cells, NK cells, |
| |
neutrophils, eosinophils, basophils |
|
granulocytes |
| |
primary lymphoid tissue |
|
bone marrow, thymus |
| |
anatomic location where stem cells reside |
|
bone marrow |
| |
anatomic site of B cell maturation |
|
bone marrow |
| |
anatomic site of T cell maturation |
|
thymus |
| |
cells that capture and present peptides to T cells |
|
antigen-presenting cells (APC) |
| |
professional antigen presenting cells |
|
dendritic cells, macrophages, B cells, FDC |
| |
Response to first exposure to an antigen |
|
primary immune response |
| |
response to repeat encounters with same antigen |
|
secondary immune response |
| |
major antibody produced in serum during primary immune response |
|
IgM |
| |
major antibody produced in serum during secondary immune response |
|
IgG |
| |
anatomic location of T cells in lymph nodes |
|
paracortex |
| |
anatomic location of B cells in lymph nodes |
|
follicle (cortex) |
| |
anatomic location of T cells in spleen |
|
periarteriolar sheath |
| |
specialized venules in lymph nodes where T cells enter |
|
high endothelial venules |
| |
cellular receptors for microbial antigens on innate immune cells |
|
pathogen recognition receptors |
| |
LPS, peptidoglycan, lipoteichoic acid, viral RNA, fungal mannans |
|
pathogen associated molecular patterns |
| |
general characteristics of innate immunity |
|
no induction period, specificity or memory |
| |
extensive physical barrier to infection |
|
epithelial lining of portals of entry |
| |
most active phagocytic cell and most abundant circulating WBC |
|
neutrophil |
| |
neutrophils, macrophages, dendritic cells, B cells |
|
phagocytic cells |
| |
lyosozyme, reactive oxygen intermediates, nitric oxide |
|
microbicidal molecules of phagocytes |
| |
enzyme responsible for production of reactive oxygen species |
|
phagocyte oxidase |
| |
pro-inflammatory cytokines that target endothelium, among others |
|
TNF, IL-1 |
| |
adhesion molecules expressed on endothelium that mediate rolling of leukocytes |
|
E and P selectins |
| |
adhesion molecules expressed on leukocytes that mediate thethering of leukocytes |
|
integrins |
| |
lymphocytes of innate immunity that provide early defense against viral infections |
|
NK cells |
| |
major sourse of interfereon-y (IFN) in innate immune system |
|
NK cellss |
| |
structural domains found on inhibitory receptors of NK cells |
|
ITIMs |
| |
structural domains found on activating receptors of NK cells |
|
ITAMs |
| |
intraepithelial lymphocytes that are early sentinels of bacterial infections |
|
gamma delta T cells |
| |
activator of classical pathway of complement |
|
antibody binding to C1q |
| |
activator of alternative pathway of complement |
|
binding of C3b to microbial surfaces |
| |
activator of lectin pathway of complement |
|
terminal mannose residues of microbial glyoproteins |
| |
major opsonin generated by complement activation |
|
C3b |
| |
pro-inflammatory molecules generated by complement activation |
|
C3a and C5a |
| |
polymeric protein complex that lyses microbes |
|
membrane attack complex (MAC), C6-C9 |
| |
cytokines that activate endothelium |
|
TNF and IL-1 |
| |
class of cytokines that increase integrin affinity and are chemotacic |
|
chemokines |
| |
cytokine that induces interfereon-gamma production by NK cells and T cells |
|
IL-12 |
| |
cytokine that activates macrophages |
|
IFNgamma |
| |
anti-viral cytokines |
|
IFNa/b (Type I IFNs) |
| |
cytokine that down-regulates immune responses |
|
IL-10 |
| |
pro-inflammatory cytokines |
|
TFN, IL-1, IL-6 |
| |
inducers of acute phase response |
|
IL-6, TNF, IL-1 |
| |
induces proliferation of plasma cells |
|
IL-6 |
| |
C-reactive protein, mannose-binding lectin and others |
|
acute phase proteins |
| |
signals generated by innate immune response to stimulate lymphocytes |
|
B7, C3d, and IL-12 |
| |
substances given with vaccines that stimulate immune responses |
|
adjuvants |
| |
neutrophils, macrophages, lymphocytes, basophils, esinophils |
|
cells quantified on a CBC |
| |